LLY

800.86

+0.72%↑

UNH

608.41

-0.32%↓

JNJ

154.75

-0.22%↓

NVO

108.76

+1.83%↑

ABBV

181.78

-0.81%↓

LLY

800.86

+0.72%↑

UNH

608.41

-0.32%↓

JNJ

154.75

-0.22%↓

NVO

108.76

+1.83%↑

ABBV

181.78

-0.81%↓

LLY

800.86

+0.72%↑

UNH

608.41

-0.32%↓

JNJ

154.75

-0.22%↓

NVO

108.76

+1.83%↑

ABBV

181.78

-0.81%↓

LLY

800.86

+0.72%↑

UNH

608.41

-0.32%↓

JNJ

154.75

-0.22%↓

NVO

108.76

+1.83%↑

ABBV

181.78

-0.81%↓

LLY

800.86

+0.72%↑

UNH

608.41

-0.32%↓

JNJ

154.75

-0.22%↓

NVO

108.76

+1.83%↑

ABBV

181.78

-0.81%↓

Search

Aptevo Therapeutics Inc

Closed

0.28 -17.65

Overview

Share price change

24h

Current

Min

0.27

Max

0.28

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+2757.14 upside

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Aptevo Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

30 Nov 2024, 12:00 UTC

Top News

Eli Lilly and Novo Nordisk's Obesity Moat Just Got Stronger -- Heard on the Street -- WSJ

30 Nov 2024, 02:00 UTC

Top News

Invest in Banking Like Warren Buffett: Own a 'Castle' -- WSJ

29 Nov 2024, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

29 Nov 2024, 21:28 UTC

Earnings

The Score: GM, Macy's, Novo Nordisk and More Stocks That Defined the Week -- WSJ

29 Nov 2024, 20:28 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly, Monthly Gains -- Market Talk

29 Nov 2024, 19:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29 Nov 2024, 19:14 UTC

Market Talk

Canadian Economy's Hidden Strengths Argue Against Big Rate Hike -- Market Talk

29 Nov 2024, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

29 Nov 2024, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29 Nov 2024, 17:09 UTC

Market Talk

Metal Prices Rise; Copper, Aluminum Remain Suppressed but Zinc Gains On-week -- Market Talk

29 Nov 2024, 16:53 UTC

Market Talk

Global Equities Roundup: Market Talk

29 Nov 2024, 16:53 UTC

Market Talk

Gold Futures Rise, Cementing a Partial Recovery After Monday's Sell-off -- Market Talk

29 Nov 2024, 16:48 UTC

Acquisitions, Mergers, Takeovers

Trump Will Be Bad for EVs But Could Be Good for Tesla, Analyst Says. Plus, Exxon Mobil, AppLovin, and More Stocks. -- Barrons.com

29 Nov 2024, 16:01 UTC

Market Talk

Bank of Canada Expected to Look at Domestic Demand, Wage Data and Cut Rates -- Market Talk

29 Nov 2024, 15:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29 Nov 2024, 15:36 UTC

Market Talk

Canada's Sluggish Economy Supports View Rates Remain Too High -- Market Talk

29 Nov 2024, 15:30 UTC

Market Talk

Bank of Canada to Weigh Narrower Output Gap Amid GDP Revisions -- Market Talk

29 Nov 2024, 15:15 UTC

Market Talk

Crude Oil Futures Move Higher With Eyes on OPEC -- Market Talk

29 Nov 2024, 15:00 UTC

Market Talk

Trade Uncertainty Could Push Bank of Canada to Cut Deeply Again -- Market Talk

29 Nov 2024, 14:27 UTC

Market Talk

U.S. Natural-Gas Futures Gain in Early Trade -- Market Talk

29 Nov 2024, 14:11 UTC

Market Talk

Business Investment in Canada Declines Again in 3Q, Exacerbating Productivity Struggle -- Market Talk

29 Nov 2024, 14:10 UTC

Market Talk

Soft Canadian Economy Argues for Another Outsize Rate Cut -- Market Talk

29 Nov 2024, 13:38 UTC

Market Talk

Canada's Economic Slowdown Leaves Door Open to December Rate Cut -- Market Talk

29 Nov 2024, 13:35 UTC

Market Talk

Canadian Per-Capita Spending Picks Up; Savings Rise -- Market Talk

29 Nov 2024, 13:09 UTC

Market Talk

Germany's Labor Market Continues to Deteriorate -- Market Talk

29 Nov 2024, 12:47 UTC

Market Talk

German Employment Data Sends Mixed Signals -- Market Talk

29 Nov 2024, 12:25 UTC

Market Talk

U.K. Households Take Precaution Amid Budget Concerns -- Market Talk

29 Nov 2024, 12:17 UTC

Market Talk

ECB Doves Get Some Wind in Their Wings -- Market Talk

29 Nov 2024, 12:06 UTC

Market Talk

Prolonged Dollar Weakness Is Unlikely in 2025, Federated Hermes Says -- Market Talk

29 Nov 2024, 12:06 UTC

Market Talk

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Aptevo Therapeutics Inc Forecast

Price Target

By TipRanks

2757.14% upside

12 Months Forecast

Average 8 USD  2757.14%

High 8 USD

Low 8 USD

Based on 1 Wall Street analysts offering 12 month price targets forAptevo Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

5.5 / 7.48Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

No Evidence

Financials

$